Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 96, Issue 12
Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Original articles
Clinical science
Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration
Online download statistics by month:
Online download statistics by month: September 2012 to May 2022
Abstract
Full
Pdf
Sep 2012
332
22
57
Oct 2012
386
41
66
Nov 2012
700
36
71
Dec 2012
687
52
80
Jan 2013
404
26
65
Feb 2013
157
27
30
Mar 2013
127
25
28
Apr 2013
76
17
15
May 2013
67
9
8
Jun 2013
56
5
5
Jul 2013
31
5
9
Aug 2013
43
5
10
Sep 2013
39
19
12
Oct 2013
34
34
8
Nov 2013
37
8
9
Dec 2013
28
5
11
Jan 2014
30
7
10
Feb 2014
18
1
4
Mar 2014
20
4
4
Apr 2014
26
5
7
May 2014
37
8
12
Jun 2014
22
5
5
Jul 2014
39
5
7
Aug 2014
13
5
6
Sep 2014
29
5
5
Oct 2014
17
7
2
Nov 2014
21
8
3
Dec 2014
18
1
3
Jan 2015
19
2
5
Feb 2015
8
3
3
Mar 2015
18
2
6
Apr 2015
20
2
5
May 2015
11
1
1
Jun 2015
16
2
5
Jul 2015
16
3
2
Aug 2015
19
1
3
Sep 2015
16
1
4
Oct 2015
10
7
5
Nov 2015
7
1
1
Dec 2015
14
3
1
Jan 2016
15
4
4
Feb 2016
15
1
2
Mar 2016
10
0
3
Apr 2016
16
1
4
May 2016
10
5
7
Jun 2016
14
0
0
Jul 2016
18
3
2
Aug 2016
23
1
1
Sep 2016
17
3
3
Oct 2016
14
0
1
Nov 2016
16
3
6
Dec 2016
21
3
3
Jan 2017
12
1
1
Feb 2017
25
2
1
Mar 2017
5
1
2
Apr 2017
15
5
2
May 2017
21
3
3
Jun 2017
19
1
2
Jul 2017
32
2
2
Aug 2017
26
1
2
Sep 2017
147
10
5
Oct 2017
309
3
5
Nov 2017
120
16
3
Dec 2017
85
30
2
Jan 2018
51
22
3
Feb 2018
80
25
1
Mar 2018
53
25
3
Apr 2018
48
22
3
May 2018
47
20
5
Jun 2018
60
28
0
Jul 2018
63
35
3
Aug 2018
47
27
2
Sep 2018
42
32
1
Oct 2018
39
18
2
Nov 2018
49
23
1
Dec 2018
57
24
4
Jan 2019
25
17
1
Feb 2019
39
16
1
Mar 2019
35
2
3
Apr 2019
13
2
1
May 2019
19
9
0
Jun 2019
32
21
1
Jul 2019
23
17
1
Aug 2019
38
18
2
Sep 2019
42
23
1
Oct 2019
45
16
0
Nov 2019
28
16
1
Dec 2019
38
18
0
Jan 2020
30
17
1
Feb 2020
37
18
0
Mar 2020
26
22
2
Apr 2020
59
23
3
May 2020
34
24
1
Jun 2020
31
17
1
Jul 2020
41
18
1
Aug 2020
26
14
0
Sep 2020
53
18
0
Oct 2020
36
16
0
Nov 2020
36
1
0
Dec 2020
49
1
0
Jan 2021
10
0
0
Feb 2021
16
1
0
Mar 2021
26
2
0
Apr 2021
12
2
2
May 2021
3
2
0
Jun 2021
1
1
1
Jul 2021
2
1
1
Aug 2021
1
0
0
Sep 2021
1
1
1
Oct 2021
22
0
0
Nov 2021
31
2
1
Dec 2021
15
0
0
Jan 2022
22
3
0
Feb 2022
18
0
0
Mar 2022
15
5
0
Apr 2022
10
0
0
May 2022
59
1
2
Total
6408
1210
716
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?